Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from the week (Monday, September 1, to Friday, September 5, 2025), and click on each link to read and watch anything you may have missed.
Tina Tan, MD, reacts to state of Florida seeking elimination of all vaccine requirements
Florida Surgeon General Joseph Ladapo announced plans to end all state vaccine mandates, calling them “wrong” and “immoral.” Although vaccinations will remain available, experts warn the move could fuel vaccine hesitancy. Tina Tan, MD, FAAP, FIDSA, FPIDS, president of the Infectious Diseases Society of America, cautioned that removing mandates may lead to confusion among parents and a rise in preventable disease outbreaks across Florida and beyond. She emphasized that health care providers must continue educating families on the benefits of vaccines to protect children and vulnerable populations.
Click play on the video above for Tina Tan's reaction to the news.
Interested in receiving a copy of the Contemporary Pediatrics journal every issue?
Want to stay up to date with pediatric news? Subscribe to the Contemporary Pediatrics e-newsletter to receive emailed updates regarding new data, pediatric clinical trials, puzzler cases, FDA news, and much more.
Click here to sign up for the free e-newsletter!
You can also follow us on LinkedIn, X, Facebook, and Blue Sky.
FDA approves first recombinant VWF for pediatric von Willebrand disease
On September 5, 2025, the FDA expanded the approval of recombinant von Willebrand factor (Vonvendi; Takeda) to include children with von Willebrand disease (VWD) for both acute bleeding episodes and surgical use. This marks the first non–plasma-derived therapy available to pediatric patients with VWD in the US, broadening access beyond its prior approvals in adults. The decision was supported by data from multiple clinical trials and real-world evidence, showing effective bleed control with most pediatric cases managed by a single infusion.
Although routine prophylaxis remains limited to adults, the expansion is expected to significantly improve care for children living with VWD, easing treatment burdens for both patients and families.
David Brousseau, MD, MS, highlights impact of timely opioid dosing in pediatric sickle cell pain
In this video interview with Contemporary Pediatrics, David Brousseau, MD, MS, pediatrician in chief and director of research at Nemours Children’s Health, highlights his study findings published in JAMA Pediatrics that underscored the importance of timely opioid administration in the emergency department for children with sickle cell disease experiencing acute pain crises.
Results showed that giving the first dose of opioids within 60 minutes was associated with decreased odds of hospitalization (OR, 0.84; 95% CI, 0.75-0.95). The impact was even greater when the second dose was administered promptly.
Click here for more study details and the full interview with David Brousseau, MD, MS.
Physicians give AI scribes a thumbs-up!
Physicians who took part in the pilot evaluation of ambient artificial intelligence (AI) scribe technology reported reduced task loads and burnout, improved efficiency and documentation quality, and ease of use.
In our latest edition of Journal Club, Jon Matthew Farber, MD, offers thoughts on using AI scribes.
Click here for the full article and comments from Dr Farber!
Richard Bermudes, MD, on screen-related addictions and youth mental health
In another video interview, Richard A. Bermudes, MD, underscored the need for pediatricians to integrate ongoing conversations into well visits.
“It gets back to what we know about addictions and what might be called behavioral addictions and how these affect the brain,” he said. "We know these are highly comorbid with other mental health conditions, specifically with anxiety and depression. And we also know that when we see these addictions with screens or social media or video games, the comorbidity rate is 30% to 40% with mood and anxiety disorders.”
Click here for the full video interview with Richard Bermudes, MD.
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
